EurekaMag
+ Translate
+ Most Popular
The pigeon tick (Argas reflexus): its biology, ecology, and epidemiological aspects
Prevalence of hemoglobin abnormalities in Kebili (Tunisian South)
Lipogranuloma: a preventable complication of dacryocystorhinostomy
Value of basal plasma cortisol assays in the assessment of pituitary-adrenal insufficiency
Bees from the Belgian Congo. The acraensis group of Anthophora
Placing gingival retraction cord
Total serum IgE, allergy skin testing, and the radioallergosorbent test for the diagnosis of allergy in asthmatic children
Acariens plumicoles Analgesoidea parasites des oiseaux du Maroc
Injuries of terminal phalanges of the fingers in children
Biology of flowering and nectar production in pear (Pyrus communis)
Das Reliktvorkommen der Aspisviper (Vipera aspis L.) im Schwarzwald
Hydrological modelling of drained blanket peatland
Pathologic morphology and clinical significance of the anomalous origin of the left circumflex coronary artery from the right coronary artery. General review and autopsy analysis of 30 cases
Cyto genetic analyses of lymphocyte cultures after exposure to calcium cyclamate
Axelrodia riesei, a new characoid fish from Upper Rio Meta in Colombia With remarks concerning the genus Axelrodia and description of a similar, sympatric, Hyphessobrycon-species
Favorable evolution of a case of tuberculosis of pancreas under antibiotic action
RIFM fragrance ingredient safety assessment, Valencene, CAS Registry Number 4630-07-3
Parenteral microemulsions: an overview
Temperate pasture: management for grazing and conservation
Evaluation of a new coprocessed compound based on lactose and maize starch for tablet formulation
Thermal expansion and cracking of three confined water-saturated igneous rocks to 800C
Revision of the genera of the tribe Stigmoderini (Coleoptera: Buprestidae) a discussion of phylogenetic relationships
Anal tuberculosis. Report of a case
Gastric tuberculosis in the past and present
Adaptive responses of the cardiovascular system to prolonged spaceflight conditions: assessment with Holter monitoring

Therapeutic Proteins for Treatment of Corneal Epithelial Defects


Therapeutic Proteins for Treatment of Corneal Epithelial Defects



Current Medicinal Chemistry 26(3): 517-545



ISSN/ISBN: 0929-8673

PMID: 28595546

Corneal epithelial disorders take pride of place in modern ophthalmology. Defects of corneal epithelium are commonly accompanied by blurry vision, photophobia and tearing. Since cornea is the most densely innervated tissue of organisms, its disruption leads to development of a severe pain syndrome. Mild corneal erosions commonly undergo quick spontaneous recovery. Suppression of corneal wound healing due to various pathological causes results in development of severe recurrent erosions and persistent corneal defects. These pathological events can in turn lead to corneal scarring, opacification, and ulceration of cornea, and ultimately to the permanent vision impairment. The etiology of the underlying corneal diseases that commonly involves inflammatory, neurotrophic and systemic factors, should be considered for treating such defects. Therefore, the research focus has been shifted to establish therapeutics based on proteins and peptides. Due to varied mechanisms of action, proteinbased pharmaceuticals can be involved in the protection of corneal surface, mimicking tear components, stimulation of corneal wound healing, regeneration of corneal innervation, suppressing oxidative stress, inflammation and neovascularization. The active components can be naturally occurring (blood- or tear-derived) or be created de novo and optimized in order to achieve the level of activity required. Such pharmaceuticals are characterized by low toxicity and absence of systemic side-effects due to their low absorption into the bloodstream, if administrated topically. This review summarizes existing data on protein-based drugs for treatment of corneal epithelial defects that are currently under preclinical development or testing in clinical trials, or approved for medical use.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 060378726

Download citation: RISBibTeXText

Related references

Topical fibronectin treatment in persistent corneal epithelial defects and corneal ulcers. Korean Journal of Ophthalmology: Kjo 4(1): 5-11, 1990

Therapeutic outcomes of combined topical autologous serum eye drops with silicone-hydrogel soft contact lenses in the treatment of corneal persistent epithelial defects: A preliminary study. Contact Lens and Anterior Eye: the Journal of the British Contact Lens Association 39(6): 425-430, 2016

Plasma rich in growth factors as a therapeutic agent for persistent corneal epithelial defects. Cornea 29(8): 843-848, 2010

Therapeutic effect of amniotic membrane in persistent epithelial defects and corneal ulcers in herpetic keratitis. Collegium Antropologicum 32(Suppl): 21-25, 2008

Abrasions, Planned Defects, and Persistent Epithelial Defects in Corneal Epithelial Wound Healing. JAMA Ophthalmology 134(10): 1176-1177, 2016

Topical anaesthetic in the treatment of corneal epithelial defects: What are the risks?. Australian Journal of General Practice 48(8): 504-506, 2019

The evaluation of eye patching in the treatment of traumatic corneal epithelial defects. Journal of Emergency Medicine 15(6): 769-774, 1997

Keratocyte apoptosis in canine spontaneous chronic corneal epithelial defects and in dogs undergoing chronic corneal epithelial debridement. IOVS Investigative Ophthalmology and Visual Science 42(4): S906, 2001

Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects. Cornea 28(10): 1104-1108, 2009

Inhibitors of plasmin-like enzymes and autofibronectin in the treatment of corneal epithelial defects. Vestnik Oftalmologii 109(4): 14-16, 1993

Modern biotechnological treatment methods of persistent corneal epithelial defects. Vestnik Oftalmologii 136(5. Vyp. 2): 277-282, 2020

Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta 4. Archives of Ophthalmology 128(5): 636-638, 2010

Treatment of chronic non-septic corneal epithelial defects in dogs using topical substance P and IGF-1. IOVS Investigative Ophthalmology and Visual Science 40(4): S337, 1999

Treatment of chronic nonhealing neurotrophic corneal epithelial defects with thymosin beta4. Annals of the new York Academy of Sciences 1194: 199-206, 2010

Finger-Prick Autologous Blood in the Treatment of Persistent Corneal Epithelial Defects. Cornea 39(5): 594-597, 2020